Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.494E-12 | 2.958E-09 | CYP1A2, CYP2A6, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.811E-11 | 5.187E-08 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 9.011E-10 | 7.849E-07 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 4.567E-09 | 2.842E-06 | CYP1A2, CYP2A13, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.477E-08 | 8.038E-06 | CYP1A2, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, NR1H4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 5.879E-08 | 2.845E-05 | CYP2A13, CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.011E-07 | 8.936E-05 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.435E-06 | 1.637E-03 | CYP2D6, CYP3A4 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 4.435E-06 | 1.637E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0071276; cellular response to cadmium ion | 7.404E-06 | 2.655E-03 | CYP1A2, EGFR, MAPK1 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.190E-03 | 1.664E-02 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.377E-05 | 1.962E-04 | CYP2A6; CYP1A2 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.497E-03 | 1.746E-02 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.712E-08 | 8.463E-07 | CYP2C9; CYP1A2; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.028E-06 | 1.953E-05 | CYP2C9; CYP2A6; CYP1A2; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.349E-26 | 1.538E-24 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.449E-10 | 9.308E-09 | CYP2C9; CYP2A6; CYP2A13; CYP2D6; CYP1A2; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.730E-10 | 9.308E-09 | CYP2C9; CYP2A6; CYP2D6; CYP1A2; CYP3A4; CYP2C19 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.383E-03 | 1.314E-02 | CYP2A6; CYP3A4 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 1.433E-02 | 4.803E-02 | CYP2C9; CYP2A6; CYP1A2; CYP2C19; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Cryptosporidium infection | A07.2 | EGFR |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
C00-D49: Neoplasms | Brain cancer | C71, D33 | EGFR; EGFR |
C00-D49: Neoplasms | Malignant tumor | C00-C75, C7A, C7B | EGFR |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9; MAPK1; EGFR |
C00-D49: Neoplasms | Locally advanced head and neck cancer | C07-C14, C32, C33 | EGFR |
C00-D49: Neoplasms | Lung cancer | C33-C34 | EGFR |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; MAPK1; EGFR |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; EGFR; EGFR; EGFR |